This book provides a concise overview of the effects of digitalization will affect healthcare provision in the coming years. Chapters focus on specific problems currently encountered in healthcare and how digital health techniques can or could potentially be used to improve provision in the future. Particular attention is given to subjects relevant to the United Nations Sustainable Development Goals, enabling the reader to develop a broad understanding of the fundamental concepts and subjects relevant to medical management in the digital age.
Health in the Era of Digitalization systematically describes the potential for digitalization to change healthcare provision for a variety of disorders and as a result of global crises. Its multi-disciplinary and problem-solving focus ensure it is a crucial resource for all those involved in relevant policy-making positions or with a general interest in the topic.
Introduction and Historical Context.- AI in Digital Health: Case Studies
in Generative AI Avatars, Conversational Interactions and Therapy, and
Clinical Trials Selection.- How can digital technology promote social justice
through lived experience leadership in addressing mental health stigma?.-
Digital Health Strategies for Women and Children.- Digital Maturity, EHRs,
and Cybersecurity.- Financing health for all in the era of digitization.-
Future projections based on current digital trends, translational research
and global care delivery models.- Role of media as a balancing body.- Digital
Health Conceptions: Space Travel, Frontier Tech and Blockchain.
Kanupriya Agarwal, MD is a physician, researcher and entrepreneur working in the field of digital and clinical medicine since 15+ years. She is currently the founder and CEO of a digital cancer startup drbot health, and is an invited advisory committee member of the Harvard Business Review. Previously, she worked at Mount Sinai Health System, NY, in different capacities including as a faculty member in digital health, engaging in curating, researching, testing and building of services and platforms in digital health for different patient communities. Amongst her work in clinical medicine and research, she has also served as a clinical investigator at Joslin Diabetes Center, Harvard Medical School. As a TEDMED Research Scholar and Stanford MedicineX speaker, she has sought to bring novel concepts in healthcare to the forefront. In addition, Kanupriya has been an invited mentor and judge at various competitions in digital health and healthcare at different levels, and has been a peer reviewer for digital health journals and conferences.
She has also been an elect member of the World Health Organization Digital Health Technical Advisory Group and Roster of Experts.
As Chief Innovation Officer at Sama Therapeutics, Russell Hanson leads iMAGiNE, a groundbreaking AI/machine-learning platform revolutionizing precision neuropsychiatry. His work leverages HuggingFace and OpenAI API platforms to develop cutting-edge AI technologies, collaborating with top pharma companies and hospitals to bring innovative solutions to market.
With 20+ years as a PhD-level AI scientist and executive, he co-founded and led AI/biotech ventures like Aptavid, delivering COVID-19 rapid diagnostics, and served as Chief Scientist at Augustus Intelligence, building enterprise-grade NLP and graph neural networks for Fortune 500 clients. Before leaving academic science, he worked as a Senior Researcher at Harvard Medical School, was on the teaching staff for Quantum Computing at MIT and served as a faculty member at the Icahn School of Medicine in New York City. He is a graduate of Reed College.
Arnaud Bernaert has more than 30 years of experience in the health care space. He has completed some 25 M&A transactions, with a particular focus on targets in home health care, clinical decision support, imaging and image-guided intervention and treatment. He is the former senior vice-president at Royal Philips and joined the World Economic Forum as head senior director of global health and health care from 2014 to 2024. When in his role à the WEF he launched a number of defining public private partnerships and coalitions in fields as diverse as digital healthcare, value based healthcare, vaccine innovation, the acceleration of research to find cures for Alzheimer, and the prevention of chronic disease with his role as a member of the WHO Independent High-level Commission on NCDs.
